Mohammad Hosny Hussein1, Eman Ali Toraih1,2, Adin Reisner3, Areej Shihabi1, Zaid Al-Quaryshi4, Jeffrey Borchardt5, Emad Kandil1. 1. Division of Endocrine and Oncologic Surgery, Department of Surgery, Tulane University School of Medicine, New Orleans, LA, USA. 2. Genetics Unit, Department of Histology and Cell Biology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt. 3. Tulane University, School of Medicine, New Orleans, LA, USA. 4. Department of Otolaryngology - Head and Neck Surgery, University of Iowa Hospitals and Clinics, Iowa City, IA, USA. 5. Department of Anesthesiology, Tulane University School of Medicine, New Orleans, LA, USA.
Abstract
Background: Diabetes is a significant and prevalent medical condition associated with increased comorbidities, longer hospital length of stay, and higher healthcare costs. We aimed to assess the association between diabetes mellitus and postoperative outcomes following pancreatic surgeries. Methods: Records for patients with major elective pancreatic surgeries were retrieved retrospectively from the Nationwide Readmission Database (2010-2014). Association of diabetic status with postoperative complications, in-hospital mortality, length of stay (LOS), readmission rate, and hospital costs were investigated. Logistic regression and decision tree analyses were employed to predict adverse outcomes. Results: A total of 8,401 patients who had pancreatic surgery were included. They were categorized according to their diabetic diagnosis. Results showed that diabetic patients had a higher risk of postoperative complications compared to non-diabetics (OR: 1.27, 95% CI: 1.08-1.49, P=0.003). Bleeding and renal complications were the most significant. Uncontrolled diabetes significantly required a longer hospital stay (9.17±4.28 vs. 8.03±4.96 days, P=0.001), and incurred higher hospital costs ($34,171.04±$20,846.61 vs. $28,182.21±$24,070.27, P=0.001). After multivariate regression, no association was found with in-hospital mortality or readmission rates; however, diabetic patients' length of stay during readmission was increased at 30- and 90-day readmissions (P=0.004 and 0.007, respectively). Conclusions: Among patients who underwent pancreatic surgery, those with diabetes had a higher rate of postoperative complications compared to non-diabetics. Additionally, diabetic patients had higher hospital charges and costs during primary admission. Initial analysis of patients with diabetes showed they had higher rates of 30- and 90-day readmissions, though this did not maintain significance after regression analysis. Exploring the mechanisms underlying this finding would aid in preventing postoperative complications and reducing healthcare costs. 2022 Gland Surgery. All rights reserved.
Background: Diabetes is a significant and prevalent medical condition associated with increased comorbidities, longer hospital length of stay, and higher healthcare costs. We aimed to assess the association between diabetes mellitus and postoperative outcomes following pancreatic surgeries. Methods: Records for patients with major elective pancreatic surgeries were retrieved retrospectively from the Nationwide Readmission Database (2010-2014). Association of diabetic status with postoperative complications, in-hospital mortality, length of stay (LOS), readmission rate, and hospital costs were investigated. Logistic regression and decision tree analyses were employed to predict adverse outcomes. Results: A total of 8,401 patients who had pancreatic surgery were included. They were categorized according to their diabetic diagnosis. Results showed that diabetic patients had a higher risk of postoperative complications compared to non-diabetics (OR: 1.27, 95% CI: 1.08-1.49, P=0.003). Bleeding and renal complications were the most significant. Uncontrolled diabetes significantly required a longer hospital stay (9.17±4.28 vs. 8.03±4.96 days, P=0.001), and incurred higher hospital costs ($34,171.04±$20,846.61 vs. $28,182.21±$24,070.27, P=0.001). After multivariate regression, no association was found with in-hospital mortality or readmission rates; however, diabetic patients' length of stay during readmission was increased at 30- and 90-day readmissions (P=0.004 and 0.007, respectively). Conclusions: Among patients who underwent pancreatic surgery, those with diabetes had a higher rate of postoperative complications compared to non-diabetics. Additionally, diabetic patients had higher hospital charges and costs during primary admission. Initial analysis of patients with diabetes showed they had higher rates of 30- and 90-day readmissions, though this did not maintain significance after regression analysis. Exploring the mechanisms underlying this finding would aid in preventing postoperative complications and reducing healthcare costs. 2022 Gland Surgery. All rights reserved.
Entities:
Keywords:
Pancreatectomy; cost; mortality; national database; readmission
Authors: Riccardo Casadei; Claudio Ricci; Giovanni Taffurelli; Anna Guariniello; Anthony Di Gioia; Mariacristina Di Marco; Nico Pagano; Carla Serra; Lucia Calculli; Donatella Santini; Francesco Minni Journal: J Gastrointest Surg Date: 2016-07-14 Impact factor: 3.452
Authors: Jerome H Liu; David S Zingmond; Marcia L McGory; Nelson F SooHoo; Susan L Ettner; Robert H Brook; Clifford Y Ko Journal: JAMA Date: 2006-10-25 Impact factor: 56.272
Authors: Leilei Xia; Jose E Pulido; Raju R Chelluri; Marshall C Strother; Benjamin L Taylor; Jay D Raman; Thomas J Guzzo Journal: BJU Int Date: 2018-01-11 Impact factor: 5.588
Authors: Javier Z Guzman; James C Iatridis; Branko Skovrlj; Holt S Cutler; Andrew C Hecht; Sheeraz A Qureshi; Samuel K Cho Journal: Spine (Phila Pa 1976) Date: 2014-09-01 Impact factor: 3.468
Authors: Benjamin F Ricciardi; Andrew Y Liu; Bowen Qiu; Thomas G Myers; Caroline P Thirukumaran Journal: Clin Orthop Relat Res Date: 2019-05 Impact factor: 4.176
Authors: Charles Qin; Elbert Vaca; Francis Lovecchio; Jon P Ver Halen; Nora M Hansen; John Y S Kim Journal: Breast Cancer Res Treat Date: 2014-06-25 Impact factor: 4.872